|
|
|
Insider
Information: |
Brennan Daniel J. |
Relationship: |
Director |
City: |
Natick |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
272,248 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$20,358,775 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
272,248 |
|
|
Total
Value |
$20,358,775 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
1
|
Stock
price went up :
|
0
|
1
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
1.0
|
Percentage
Gain/Loss : |
0.0%
|
8.8%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Boston Scientific Corp |
BSX |
EVP and CFO |
2024-02-20 |
271,542 |
|
0 |
Premium* |
|
Nuance Communications Inc |
NUAN |
Director |
2022-03-04 |
0 |
2018-09-10 |
0 |
Premium* |
|
Waters Corp |
WAT |
Director |
2024-01-02 |
706 |
2022-11-23 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
169 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 6 of 7
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2024-02-17 |
4 |
D |
$65.82 |
$133,812 |
D/D |
(2,033) |
269,480 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2019-10-02 |
4 |
OE |
$7.41 |
$151,623 |
D/D |
20,462 |
235,422 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2020-02-13 |
4 |
OE |
$7.41 |
$151,631 |
D/D |
20,463 |
250,710 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2016-02-22 |
4 |
D |
$17.26 |
$151,819 |
D/D |
(8,796) |
158,825 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2022-01-01 |
4 |
D |
$42.48 |
$172,341 |
D/D |
(4,057) |
272,379 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2021-02-23 |
4 |
OE |
$7.16 |
$177,897 |
D/D |
24,846 |
307,198 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2024-02-20 |
4 |
OE |
$13.08 |
$178,699 |
D/D |
13,662 |
285,204 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2023-01-01 |
4 |
D |
$46.27 |
$187,023 |
D/D |
(4,042) |
273,382 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2017-01-01 |
4 |
D |
$21.63 |
$210,936 |
D/D |
(9,752) |
170,687 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2018-01-01 |
4 |
D |
$24.79 |
$240,959 |
D/D |
(9,720) |
234,425 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2021-02-10 |
4 |
D |
$38.85 |
$261,072 |
D/D |
(6,720) |
272,718 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2021-01-01 |
4 |
D |
$35.95 |
$265,886 |
D/D |
(7,396) |
280,326 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2020-01-01 |
4 |
D |
$45.22 |
$297,457 |
D/D |
(6,578) |
230,247 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2023-02-15 |
4 |
AS |
$47.14 |
$356,927 |
D/D |
(7,572) |
276,316 |
0 |
% |
|
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2021-03-02 |
4 |
AS |
$38.84 |
$368,034 |
D/D |
(9,475) |
275,370 |
0 |
% |
|
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2019-01-01 |
4 |
D |
$35.34 |
$376,124 |
D/D |
(10,643) |
301,621 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2022-02-15 |
4 |
AS |
$43.47 |
$397,142 |
D/D |
(9,136) |
266,177 |
0 |
% |
|
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2021-03-03 |
4 |
AS |
$38.69 |
$469,177 |
D/D |
(12,127) |
263,243 |
0 |
% |
|
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2024-01-01 |
4 |
D |
$57.81 |
$473,984 |
D/D |
(8,199) |
241,738 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2022-03-02 |
4 |
AS |
$44.03 |
$485,650 |
D/D |
(11,029) |
264,290 |
0 |
% |
|
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2018-03-19 |
4 |
OE |
$6.28 |
$513,465 |
D/D |
60,209 |
339,392 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2022-02-16 |
4 |
AS |
$43.70 |
$532,580 |
D/D |
(12,187) |
266,177 |
0 |
% |
|
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2018-02-12 |
4 |
D |
$26.18 |
$582,872 |
D/D |
(22,264) |
265,809 |
0 |
- |
|
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2021-01-05 |
4 |
AS |
$35.32 |
$603,407 |
D/D |
(17,083) |
263,243 |
0 |
% |
|
BSX |
Boston Scientific Corp |
EVP and CFO |
|
2016-02-24 |
4 |
OE |
$0.00 |
$668,555 |
D/D |
92,496 |
254,941 |
0 |
- |
|
169 Records found
|
|
Page 6 of 7 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|